
### [NCIT:C9292](http://purl.obolibrary.org/obo/NCIT_C9292)
**Label:** Solid Neoplasm

**Subclasses:** [NCIT:C132146](http://purl.obolibrary.org/obo/NCIT_C132146) (Malignant Solid Neoplasm), [NCIT:C9107](http://purl.obolibrary.org/obo/NCIT_C9107) (Childhood Solid Neoplasm), [NCIT:C133737](http://purl.obolibrary.org/obo/NCIT_C133737) (Refractory Malignant Solid Neoplasm), [NCIT:C127155](http://purl.obolibrary.org/obo/NCIT_C127155) (Metastatic Malignant Solid Neoplasm), [NCIT:C127153](http://purl.obolibrary.org/obo/NCIT_C127153) (Recurrent Malignant Solid Neoplasm), [NCIT:C8101](http://purl.obolibrary.org/obo/NCIT_C8101) (Adult Solid Neoplasm), 

**Class expressions from DL-Learner:**

- [NCIT:C60643](http://purl.obolibrary.org/obo/NCIT_C60643) (Adulthood Lesion) 66.67%
- Thing 51.41%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 45.53%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 36.34%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 36.00%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 36.00%
- [UBERON:0034769](http://purl.obolibrary.org/obo/UBERON_0034769) (lymphomyeloid tissue) 31.74%
- [UBERON:0015757](http://purl.obolibrary.org/obo/UBERON_0015757) (heterogeneous tissue) 31.74%
- [UBERON:0000479](http://purl.obolibrary.org/obo/UBERON_0000479) (tissue) 21.21%
- [CL:0000000](http://purl.obolibrary.org/obo/CL_0000000) (cell) 20.27%
- [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) 20.22%
- [UBERON:0010000](http://purl.obolibrary.org/obo/UBERON_0010000) (multicellular anatomical structure) 19.13%
- [UBERON:0000061](http://purl.obolibrary.org/obo/UBERON_0000061) (anatomical structure) 19.06%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 19.04%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 18.77%


